+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid improves hepatic metabolism of essential fatty acid and retinol in cystic fibrosis children



Ursodeoxycholic acid improves hepatic metabolism of essential fatty acid and retinol in cystic fibrosis children



FASEB Journal 9(3): A441




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144828

Download citation: RISBibTeXText


Related references

Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis. Journal of Pediatrics 130(1): 52-58, 1997

Ursodeoxycholic acid improves hepatic metabolism of essential fatty acids and retinol in pancreatic cystic fibrosis. M-S (Medecine Sciences) 11(SUPPL 2): 21, 1995

Ursodeoxycholic acid improves essential fatty acid deficiency in cystic fibrosis. Hepatology 18(4 PART 2): 271A, 1993

Long chain fatty acid metabolism and essential fatty acid deficiency with special emphasis on cystic fibrosis. Bracco, U. And R. J. Deckelbaum (ed.). Nestle Nutrition Workshop Series, Vol. 28. Polyunsaturated Fatty Acids In Human Nutrition; Meeting, Mexico City, Mexico, November 27-30,. Xi 243p. Nestec Ltd: Vevey, Switzerland; Raven Press: New York, New York, Usa. Illus. 159-167, 1992

Two cases of cystic fibrosis in Japanese children: studies on the essential fatty acid and prostaglandin metabolism. Acta Paediatrica Japonica 31(2): 205-210, 1989

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology 23(6): 1484-1490, 1996

Essential-fatty-acid metabolism in cystic fibrosis. Lancet ii(7942): 983, 1975

Defective essential-fatty-acid metabolism in cystic fibrosis. Lancet ii(7936): 642-643, 1975

Ursodeoxycholic acid improves cholestasis in infants with cystic fibrosis. Annals of PharmacoTherapy 31(9): 1003-1005, 1997

Lipoprotein metabolism in cystic fibrosis role of essential fatty acid deficiency. Gastroenterology 96(5 PART 2): A621, 1989

Relation between essential fatty acid metabolism and gastrointestinal symptoms in cystic fibrosis. Acta Paediatrica Scandinavica. Suppl. 363: 58-63; Discussion 63-5, 1989

No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis. Journal of Lipid Research 45(12): 2277-2286, 2004

Metabolism of lipoproteins in cystic fibrosis patients with essential fatty acid deficiency efad. Clinical & Investigative Medicine 15(4 SUPPL): A111, 1992

Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition 47(5): 635-644, 2008

Use of ursodeoxycholic acid in hepatic lesion in patients with cystic fibrosis. Rossiiskii Vestnik Perinatologii i Pediatrii 47(6): 23-26, 2002